Skip to main content
NVDA+0.22%AAPL+0.02%GOOGL-0.61%MSFT-0.02%AMZN+0.10%TSM+0.96%SPCX+5.15%META+0.13%AVGO+0.07%TSLA+0.04%SKHY+0.02%BRK-B+0.59%LLY+0.18%MU+0.34%JPM-1.01%WMT-0.55%AMD+1.65%V-1.25%XOM-3.54%JNJ+0.03%ASMLa+1.26%INTC+4.03%0700.HK-1.23%MA-0.96%ABBV-0.17%1398.HK+0.67%CSCO-2.12%CVX-2.86%BAC-2.72%ORCL+2.00%COST-0.84%KO-0.95%DELL+3.64%CAT-0.10%0005.HK+0.81%PG+0.24%HSBA.L+0.27%UNH-0.18%LRCX-0.61%AP2d+0.95%AMAT-1.37%GE+1.91%MS-1.83%3988.HK+0.34%1816.HK-0.69%NFLX-1.91%0857.HK-1.90%HD-0.99%PM-1.24%0939.HK+0.31%USDJPY+1.76%NZDUSD-1.69%USDCHF+1.16%EURUSD-1.15%AUDUSD-1.14%USDPLN+1.11%GBPUSD-1.05%USDTHB+1.03%CADJPY+0.92%USDNOK+0.91%USDSEK+0.89%NZDCAD-0.89%USDZAR+0.89%USDCAD+0.84%CHFJPY+0.68%GBPJPY+0.67%GBPNZD+0.65%EURHKD-0.65%USDDKK+0.65%EURCNH-0.65%AUDJPY+0.62%NZDCHF-0.58%USDMXN+0.57%EURJPY+0.57%EURNZD+0.56%AUDNZD+0.56%CHFSGD-0.45%EURPLN+0.45%USDSGD+0.42%GBPTRY+0.41%PLNJPY-0.36%NZDSGD-0.35%EURCAD-0.35%SGDJPY+0.32%GBPHKD+0.32%AUDNOK+0.32%CADCHF+0.32%AUDCAD-0.30%GBPMXN-0.28%GBPSGD-0.27%EURNOK+0.26%EURSEK+0.24%GBPCAD-0.23%EURSGD-0.23%USDTRY+0.23%EURZAR+0.22%GBPZAR+0.19%NZDMXN-0.18%AUDSGD-0.17%USDILS+0.16%NOKJPY-0.16%GBPCHF+0.08%EURCZK+0.07%GBPAUD+0.07%EURGBP-0.07%USDCNH+0.07%AUDDKK+0.06%USDCOP-0.04%CHFNOK+0.03%USDHKD+0.03%AUDCHF+0.02%CHFSEK+0.02%EURCHF+0.02%NZDJPY+0.01%EURAUD+0.01%EURDKK0.00%USOIL-3.37%UKOIL-2.66%XNGUSD-1.46%GAGUSD-1.06%XAGUSD-1.06%XPTUSD-0.72%GAUUSD-0.69%XAUUSD-0.69%HG1-0.29%COFFEE0.00%COCOA0.00%COTTON0.00%BTCUSD+0.65%ETHUSD+0.48%USDTUSD0.00%XRPUSD+1.59%SOLUSD+1.71%TRXUSDT+0.88%ZECUSDT+19.18%DOGEUSD+0.79%XMRUSDT-2.56%LINKUSD+0.67%XLMUSD+4.16%BCHUSDT+0.91%UNIUSD+1.88%LTCUSD+0.03%TONUSD+29.54%HBARUSDT-0.94%SUIUSD+3.49%TAOUSDT+1.54%AAVEUSD-2.57%DOTUSDT+6.14%ICPUSDT+1.32%ONDOUSDT+3.44%WLDUSDT+2.66%ARBUSDT+7.07%ATOMUSDT-0.95%JUPUSDT+0.20%INJUSDT-0.84%STXUSDT+0.30%FETUSDT+2.51%PYTHUSDT-0.57%TIAUSDT+2.39%SEIUSDT+1.07%IMXUSDT-1.25%GRTUSDT+1.45%OPUSDT-0.14%WIFUSDT+1.97%POLUSDT+0.22%IOTAUSDT-0.47%AXSUSDT-0.41%FARTCOINUSDT+0.03%EOSUSDT-0.58%DYDXUSDT+0.16%ORDIUSDT+2.37%GALAUSDT-2.15%NOTUSDT+1.37%RONINUSDT-2.40%NVDA+0.22%AAPL+0.02%GOOGL-0.61%MSFT-0.02%AMZN+0.10%TSM+0.96%SPCX+5.15%META+0.13%AVGO+0.07%TSLA+0.04%SKHY+0.02%BRK-B+0.59%LLY+0.18%MU+0.34%JPM-1.01%WMT-0.55%AMD+1.65%V-1.25%XOM-3.54%JNJ+0.03%ASMLa+1.26%INTC+4.03%0700.HK-1.23%MA-0.96%ABBV-0.17%1398.HK+0.67%CSCO-2.12%CVX-2.86%BAC-2.72%ORCL+2.00%COST-0.84%KO-0.95%DELL+3.64%CAT-0.10%0005.HK+0.81%PG+0.24%HSBA.L+0.27%UNH-0.18%LRCX-0.61%AP2d+0.95%AMAT-1.37%GE+1.91%MS-1.83%3988.HK+0.34%1816.HK-0.69%NFLX-1.91%0857.HK-1.90%HD-0.99%PM-1.24%0939.HK+0.31%USDJPY+1.76%NZDUSD-1.69%USDCHF+1.16%EURUSD-1.15%AUDUSD-1.14%USDPLN+1.11%GBPUSD-1.05%USDTHB+1.03%CADJPY+0.92%USDNOK+0.91%USDSEK+0.89%NZDCAD-0.89%USDZAR+0.89%USDCAD+0.84%CHFJPY+0.68%GBPJPY+0.67%GBPNZD+0.65%EURHKD-0.65%USDDKK+0.65%EURCNH-0.65%AUDJPY+0.62%NZDCHF-0.58%USDMXN+0.57%EURJPY+0.57%EURNZD+0.56%AUDNZD+0.56%CHFSGD-0.45%EURPLN+0.45%USDSGD+0.42%GBPTRY+0.41%PLNJPY-0.36%NZDSGD-0.35%EURCAD-0.35%SGDJPY+0.32%GBPHKD+0.32%AUDNOK+0.32%CADCHF+0.32%AUDCAD-0.30%GBPMXN-0.28%GBPSGD-0.27%EURNOK+0.26%EURSEK+0.24%GBPCAD-0.23%EURSGD-0.23%USDTRY+0.23%EURZAR+0.22%GBPZAR+0.19%NZDMXN-0.18%AUDSGD-0.17%USDILS+0.16%NOKJPY-0.16%GBPCHF+0.08%EURCZK+0.07%GBPAUD+0.07%EURGBP-0.07%USDCNH+0.07%AUDDKK+0.06%USDCOP-0.04%CHFNOK+0.03%USDHKD+0.03%AUDCHF+0.02%CHFSEK+0.02%EURCHF+0.02%NZDJPY+0.01%EURAUD+0.01%EURDKK0.00%USOIL-3.37%UKOIL-2.66%XNGUSD-1.46%GAGUSD-1.06%XAGUSD-1.06%XPTUSD-0.72%GAUUSD-0.69%XAUUSD-0.69%HG1-0.29%COFFEE0.00%COCOA0.00%COTTON0.00%BTCUSD+0.65%ETHUSD+0.48%USDTUSD0.00%XRPUSD+1.59%SOLUSD+1.71%TRXUSDT+0.88%ZECUSDT+19.18%DOGEUSD+0.79%XMRUSDT-2.56%LINKUSD+0.67%XLMUSD+4.16%BCHUSDT+0.91%UNIUSD+1.88%LTCUSD+0.03%TONUSD+29.54%HBARUSDT-0.94%SUIUSD+3.49%TAOUSDT+1.54%AAVEUSD-2.57%DOTUSDT+6.14%ICPUSDT+1.32%ONDOUSDT+3.44%WLDUSDT+2.66%ARBUSDT+7.07%ATOMUSDT-0.95%JUPUSDT+0.20%INJUSDT-0.84%STXUSDT+0.30%FETUSDT+2.51%PYTHUSDT-0.57%TIAUSDT+2.39%SEIUSDT+1.07%IMXUSDT-1.25%GRTUSDT+1.45%OPUSDT-0.14%WIFUSDT+1.97%POLUSDT+0.22%IOTAUSDT-0.47%AXSUSDT-0.41%FARTCOINUSDT+0.03%EOSUSDT-0.58%DYDXUSDT+0.16%ORDIUSDT+2.37%GALAUSDT-2.15%NOTUSDT+1.37%RONINUSDT-2.40%
LT

Lexeo Therapeutics, Inc. Common Stock (LXEO)

NASDAQ • Healthcare

$4.16
+$0.03 (+0.7%)
Market closed

Last close at September 16, 2026 at 20:00 UTC

Open$4.16
Day Range$4.09 - $4.22
Avg. Volume (3M)683.9K
Market Cap$329.7M
52 Week Range
$3.99$10.99
Next EarningsIn 89 daysDec 14, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$87.2M
EPS (TTM)
-$1.15
ROA (TTM)
-34.24%
Current Ratio
13.89

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+15.6%Q1 2026-$0.27
+13.8%Q2 2026-$0.25
-5.2%Q3 2026-$0.3
Next

Dec 14

in 89 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -5.2%

Lexeo Therapeutics’ preliminary second fiscal quarter of 2026 results, reported Aug. 12, missed EPS consensus, with a loss of $0.30 per share versus a $0.29 estimate, -5%. Based on preliminary results, EPS of -$0.30 was up 50% from a $0.60 loss a year ago, and net income came in at a loss of about $25.9 million, up 1% from a $26.1 million loss a year earlier. Operating income was a loss of roughly $28.0 million, and operating cash flow was negative $17.6 million. Consensus for the next period calls for EPS of -$0.32.

View full earnings history

About Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. is a clinical-stage Biotechnology company listed on NASDAQ as LXEO. The company develops gene therapies for genetically defined cardiovascular and neurologic diseases, with a pipeline centered on inherited cardiomyopathies, APOE4-targeted programs, and CLN2 Batten disease in patients with rare, mutation-linked disorders.

Name
Lexeo Therapeutics, Inc. Common Stock
CEO
R. Nolan Townsend
Website
www.lexeotx.com
Industry
Healthcare
Year Founded
2017
Employees
63

Today's Snapshot

AI-generated

The day ended with LXEO 0.7% higher at 4.16, while its sector was flat. At the close, LXEO was within 4.3% of its 52-week low of 3.99.

Trading Volume

Below 10d avg (633.9K)

609.9K

vs S&P 500 Today

Outperforming Market

+1.31%

Updated: September 16, 2026 at 20:08 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
LXEO shows a predominantly negative technical picture with weak trend strength—ADX under 18—while momentum indicators are deeply negative and the stock trades well below its 200-day average, indicating sustained longer-term pressure. Short-term oscillators are signaling oversold conditions and may temper selling, however on-balance volume and multiple moving averages align with a bearish bias, and volatility is elevated relative to price. Taken together, the weight of negative averages and weak volume argues for caution. Technical takeaway: Sell — downside bias persists amid weak trend and negative volume despite short-term oversold signals.
All signals
  • EMA (5 indicators)$4.41 - $6.13
    Sell
  • RSI (14)34.73
    Neutral
  • Stochastic %K (14, 3, 3)9.32
    Buy
  • MACD Level (12, 26)-0.15
    Sell

Peers & Related Assets

CAPRCapricor Therapeutics, Inc.
$8.560.0%
LRMRLarimar Therapeutics, Inc.
$3.93+0.5%
VNDAVanda Pharmaceuticals Inc.
$5+0.2%
VYGRVoyager Therapeutics, Inc.
$3.05-1.3%
SLNSilence Therapeutics plc
CTNMContineum Therapeutics, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.